Cargando…
Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
According to the World Health Organisation (WHO), as of week 23 of 2022, there were more than 1,311 cases of dengue in Malaysia, with 13 deaths reported. Furthermore, there was an increase of 65.7% during the same period in 2021. Despite the increase in cumulative dengue incidence, there is no effec...
Autores principales: | Salin, Nurul Hanim, Hariono, Maywan, Khalili, Nur Sarah Dyana, Zakaria, Iffah Izzati, Saqallah, Fadi G., Mohamad Taib, Mohamad Nurul Azmi, Kamarulzaman, Ezatul Ezleen, Wahab, Habibah A., Khawory, Muhammad Hidhir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715268/ https://www.ncbi.nlm.nih.gov/pubmed/36465554 http://dx.doi.org/10.3389/fmolb.2022.875424 |
Ejemplares similares
-
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling
por: Hariono, Maywan, et al.
Publicado: (2019) -
Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies
por: Salin, Nurul Hanim, et al.
Publicado: (2020) -
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
por: Norshidah, Harun, et al.
Publicado: (2023) -
Development of a NS2B/NS3 protease inhibition assay using AlphaScreen(®) beads for screening of anti-dengue activities
por: Abduraman, Muhammad Asyraf, et al.
Publicado: (2018) -
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies
por: Hariono, Maywan, et al.
Publicado: (2021)